For example, Yang et al. developed a BRD4-targeting PROTAC nanodrug, termed SPP-ARV-825, for glioma therapy by employing a polymeric micelle platform designed to enhance blood–brain barrier (BBB) penetration and tumor targeting [46]. The gene discussed is BRD4; the disease is central nervous system cancer.